D47.1
Chronic myeloproliferative disease
Clinical Classification Guidelines
Inclusion Terms
- Chronic neutrophilic leukemia
- Myeloproliferative disease, unspecified
Excludes Type 1
- atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
- chronic myeloid leukemia BCR/ABL-positive (C92.1-)
- myelofibrosis NOS (D75.81)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- secondary myelofibrosis NOS (D75.81)
Medical Intelligence & Overview
Chronic myeloproliferative disease is a group of disorders characterized by the abnormal overproduction of blood cells in the bone marrow. This condition, categorized under ICD-10 code D47.1, includes diseases like chronic neutrophilic leukemia and other unspecified myeloproliferative disorders. These diseases develop gradually and can affect the production of different blood cell types, leading to a range of health issues.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting blood cell production Abnormal growth signals in the bone marrow Environmental factors that may influence bone marrow function Possibility of progression from other blood disorders
Key Symptoms: Excessive fatigue Night sweats Unexplained weight loss Enlarged spleen or liver Frequent infections Bleeding or bruising easily Unusual blood counts detected in tests
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of blood tests such as complete blood count (CBC), bone marrow biopsy, and genetic testing to identify mutations linked to myeloproliferative diseases. These steps help differentiate between various types and determine the extent of overproduction of blood cells. Medical history and physical examinations are also crucial in establishing the diagnosis.
Treatment Protocols: Treatment options may include medication to reduce blood cell production, control symptoms, and prevent complications. Some common approaches are such as chemotherapy, targeted therapy, and blood thinners. In certain cases, procedures like blood transfusions or stem cell transplants might be considered. Regular monitoring is essential to adjust treatment plans as needed.
Clinical Advice & FAQs
Billing Guidance
Is D47.1 a billable ICD-10 code?
Yes, D47.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D47.1?
Clinical documentation must specify the nature of Chronic myeloproliferative disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference